[Figure 2](#pone-0101827-g001){ref-type="fig"} is incorrect; panels C-F are missing. The figure legend is correct. The authors have provided a corrected version here.

![K1492 and K1861 form aggressive intracranial tumours and MYXV treatment results in no efficacy and minimal viral infection with no viral replication.\
**A** -- Histopathology of 14 day K1492 and K1861 by H&E (first column 25×, second column 200×) and astrocytic markers S100b (200×) and GFAP (200×). 5×10^4^ cells of K1492 (**B**) and K1861 (**C**) were intracranially implanted in C57Bl/6J mice and received 5×10^6^ PFUs vMyx-FLuc (MYXV), UV-inactivated virus (DV), PBS, or no treatment (NT) on day 14. **D** -- Luciferase measured (Total FLUX) from region-of-interest around the entire mouse skull following 5×10^6^ PFUs vMyx-FLuc in K1492 (n  =  8), K1861 (n  =  10) or no tumour (n  =  5). Error bars represent standard error. **E** -- Viral recovery from K1492 (n  =  4) and K1861 (n  =  4) tumours following intracranial treatment with vMyx-FLuc. Input virus represents mice where virus was recovered 1 hour post-injection. Error bars represent standard error. **F** -- Immunohistochemical staining for early MYXV protein MT-7e in 14 day K1492 at 1, 3 and 7 days post-treatment (Top row 25×; Bottom row 100×).](pone.0101827.g001){#pone-0101827-g001}
